Cannabidiol (CBD): An Innovative Pharmacological Treatment for Obsessive Compulsive Disorder (OCD)
DOI:
https://doi.org/10.37591/rrjon.v7i1.965Abstract
Obsessive Compulsive Disorder (OCD) is characterized by recurring and repetitious thoughts coupled to anxiety characterized by obsessive thoughts and associated compulsive behavior(s). OCD patient often fears that the anxiety will not abate and obsessional thoughts will control her/his mind or body in advocating or carrying out unwanted compulsive behaviors. Such thinking patterns or behaviors may often be frightening but usually they are quite harmless except when promoting accompanying anxiogenic activity. Confused thinking may be severe enough to cause functional impairments when obsessions or compulsions dominate mental status. In OCD, disrupted thoughts and actions may dominate the normal conduct of everyday tasks. Anxiety caused by obsessive thoughts is usually relieved by time-consuming and significant effort-requiring compulsive behaviors. Compulsive activities like diversionary counting, checking behavior (e.g., like repeatedly checking whether the stove is on or off), or excessive cleaning activity dominate the response to obsessive thoughts. Excessive hand washing (sometimes called the Pontius Pilot Syndrome) occurring as a compulsive behavior, not only relieves the causal obsession but serves as a “refresh button” (i.e., like that found on a computer)--clearing the mind of obsessions, compulsive urges, and extraneous thoughts. The major extracts of the Cannabis sativa plant are primarilydelta9-THC (causing intoxication, psychosis, often anxiety) and secondarily the non-psychotomimetic compound Cannabidiol (CBD). Studies have found multiple therapeutic actions in the uses of CBD—with anxiolytic activities (i.e., opposing the anxiogenic actions of delta9-THC), anti-psychotic activities, and lessening of the compulsions that occur with OCD and other psychiatric conditions.
Keywords: Obsessive-compulsive disorder (OCD), cannabidiol (CBD), anxiety-related disorders
Cite this Article
P. Flaer, M. AlRubaie. Cannabidiol (CBD): An Innovative Pharmacological Treatment for Obsessive Compulsive Disorder (OCD). Research & Reviews: Journal of Neuroscience. 2017; 7(1): 12–16p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
